immune response News
Most Popular immune response Story
Transgene to partner after cancer vax passes trial
France's Transgene is taking the wraps off of positive Phase IIb data for its experimental cancer vaccine, TG4010. The European trial of 148 patients saw progression-free survival of 44 percent of Read more...
Latest Headlines
- March 26, 2008
- March 11, 2008
- February 7, 2008
- December 11, 2007
- November 1, 2007
- October 29, 2007
- January 17, 2007
- December 10, 2006
- September 27, 2006
- September 6, 2006
- May 31, 2006
- March 29, 2006
- March 21, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
